Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYPLOS Pathogens

Human cytomegalovirus antagonizes SMC5/6 driven genome silencing via UL35 instituted proteasomal degradation of SLF2

4 affiliations
  1. 1Institute of Virology, Ulm University Medical Center, Ulm, Germany.
  2. 2Public Health Office, City of Sapporo, Sapporo, Japan.
  3. 3Institute of Genetics and Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany.
  4. 4Virology and Innate Immunity Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Abstract

Recent studies demonstrated that the structural maintenance of chromosomes complex 5/6 (SMC5/6) acts as an important antiviral restriction factor that silences episomal DNA. Consequently, viruses have evolved strategies to antagonize this defence system. Interestingly, it was shown that SMC5/6-mediated silencing of extrachromosomal DNA depends on its recruitment to PML nuclear bodies (PML-NBs) which is mediated by a protein termed SMC5/6 localization factor 2 (SLF2). Since human cytomegalovirus (HCMV) dissociates PML nuclear bodies during the first hours of infection, we asked for the fate of SMC5/6 components during the HCMV replicative cycle. We first investigated the expression levels of SMC5/6 core components at the onset of HCMV infection and found that they were not downregulated by HCMV. Instead, we observed a distinct decrease of SLF2 protein levels which correlated with a complete dispersal of the SMC5/6 complex from PML-NBs. This was also observed after infection with UV-inactivated HCMV and could not be blocked by cycloheximide treatment suggesting the involvement of an imported structural component of the virion. While we could exclude a requirement of the HCMV tegument protein pp71 (UL82), a targeted screen identified the tegument protein UL35 as being required and sufficient for proteasomal degradation of SLF2. In line with these results, SLF2 levels remained stable after infection with a recombinant HCMV harbouring a stop codon within the UL35 gene region and this correlated with a defect in the onset of HCMV immediate early gene expression. Furthermore, we observed an enhanced recruitment of SMC5/6 to PML-NBs and an overall increase in the association of parental viral genomes with SMC5/6 containing PML-NBs in the absence of UL35. Congruently, siRNA mediated depletion of SLF2 resulted in a reversal of this phenotype. This strongly suggests that UL35 serves as a novel viral SLF2 antagonist to prevent the initial silencing of incoming viral genomes by SMC5/6. Author summary: Human cytomegalovirus (HCMV) is an important human pathogen which establishes a life-long persistent infection. Previous research revealed that host intrinsic defense mechanisms can silence HCMV gene expression and thereby foster latency. However, during lytic infection, viral effector proteins like the structural protein pp71 (UL82) and the viral immediate-early protein IE1 act as antagonists of this defense. Here, we report on the identification of a novel antagonist of host-mediated viral gene silencing which targets the SMC5/6 complex. SMC5/6 belongs to a highly conserved family of protein complexes that act as loop extrusion machines to facilitate the folding of chromatin. While SMC5/6 core factors were not attacked by HCMV, we found that degradation of the SMC5/6 associated protein SLF2 was induced by the viral tegument protein UL35, that is imported into infected cells. This abrogates the accumulation of SMC5/6 at PML nuclear bodies which compromises the entrapment of viral genomes in these subnuclear structures. Since SLF2 is also important for genome stability and pathogenic variants of SLF2 cause the neurodevelopmental disease Atelis syndrome, we speculate that depletion of this factor via a viral tegument protein may also contribute to DNA damage induced during congenital HCMV infection.

Related

  1. Repurposing ritonavir to induce proteasomal degradation of IE1 for inhibition of human cytomegalovirus replication
    Wanfeng Liu, Yu Shi, Xudong Guo +7
    PLOS Computational BiologyPeer-reviewedCC BYFull textMolecular biology & gene regulationImmunologyPLOSEurope PMC
  2. Epigenetic silencing of PDLIM4 promotes colorectal cancer by impairing BTF3 autophagic degradation and activating PI3K/Akt signalling.
    Jiaxing Wang, Chuan-Guo Guo, Lingyu Qi +8
    Clinical and translational medicinePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  3. Grb2 phosphorylation antagonizes EGFR-driven ras activation by interfering with condensate assembly
    Henry T Phan, Chun-Wei Lin, Brittany L Stinger +4
    PLOS OnePeer-reviewedCC BYFull textEnzymology & metabolismCell biologyPLOSEurope PMC
  4. Substrate secondary structure is associated with proteasomal cleavage propensity.
    Matheus De Bastos Balbé Gutierres, Finn Beruldsen, Dinler Amaral Antunes +1
    Frontiers in bioinformaticsPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  5. Heparan Sulfate Differentially Regulates Fibroblast Binding by Extracellular Vesicles and Human Cytomegalovirus
    Vladimir Bokun, Antonio Di Maio, Yibing Zhang +3
    Journal of extracellular vesiclesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{montagner2026human,
  title = {{Human cytomegalovirus antagonizes SMC5/6 driven genome silencing via UL35 instituted proteasomal degradation of SLF2}},
  author = {Francesco Montagner and Myriam Scherer and Cora Stegmann and Friedrich Hahn and Claudia Ploil and Christina Sandra Einsiedler and Elena Katharina Brosch and Takahiro Maeki and Ramya Ramani and Nicole Andrée-Busch and Melanie M Brinkmann and Thomas Stamminger},
  journal = {PLOS Pathogens},
  year = {2026},
  month = oct,
  doi = {10.1371/journal.ppat.1014709},
  url = {https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014709},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Human cytomegalovirus antagonizes SMC5/6 driven genome silencing via UL35 instituted proteasomal degradation of SLF2
AU  - Francesco Montagner
AU  - Myriam Scherer
AU  - Cora Stegmann
AU  - Friedrich Hahn
AU  - Claudia Ploil
AU  - Christina Sandra Einsiedler
AU  - Elena Katharina Brosch
AU  - Takahiro Maeki
AU  - Ramya Ramani
AU  - Nicole Andrée-Busch
AU  - Melanie M Brinkmann
AU  - Thomas Stamminger
PY  - 2026
DA  - 2026/10/12
JO  - PLOS Pathogens
DO  - 10.1371/journal.ppat.1014709
UR  - https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014709
AB  - Recent studies demonstrated that the structural maintenance of chromosomes complex 5/6 (SMC5/6) acts as an important antiviral restriction factor that silences episomal DNA. Consequently, viruses have evolved strategies to antagonize this defence system. Interestingly, it was shown that SMC5/6-mediated silencing of extrachromosomal DNA depends on its recruitment to PML nuclear bodies (PML-NBs) which is mediated by a protein termed SMC5/6 localization factor 2 (SLF2). Since human cytomegalovirus (HCMV) dissociates PML nuclear bodies during the first hours of infection, we asked for the fate of SMC5/6 components during the HCMV replicative cycle. We first investigated the expression levels of SMC5/6 core components at the onset of HCMV infection and found that they were not downregulated by HCMV. Instead, we observed a distinct decrease of SLF2 protein levels which correlated with a complete dispersal of the SMC5/6 complex from PML-NBs. This was also observed after infection with UV-inactivated HCMV and could not be blocked by cycloheximide treatment suggesting the involvement of an imported structural component of the virion. While we could exclude a requirement of the HCMV tegument protein pp71 (UL82), a targeted screen identified the tegument protein UL35 as being required and sufficient for proteasomal degradation of SLF2. In line with these results, SLF2 levels remained stable after infection with a recombinant HCMV harbouring a stop codon within the UL35 gene region and this correlated with a defect in the onset of HCMV immediate early gene expression. Furthermore, we observed an enhanced recruitment of SMC5/6 to PML-NBs and an overall increase in the association of parental viral genomes with SMC5/6 containing PML-NBs in the absence of UL35. Congruently, siRNA mediated depletion of SLF2 resulted in a reversal of this phenotype. This strongly suggests that UL35 serves as a novel viral SLF2 antagonist to prevent the initial silencing of incoming viral genomes by SMC5/6. Author summary: Human cytomegalovirus (HCMV) is an important human pathogen which establishes a life-long persistent infection. Previous research revealed that host intrinsic defense mechanisms can silence HCMV gene expression and thereby foster latency. However, during lytic infection, viral effector proteins like the structural protein pp71 (UL82) and the viral immediate-early protein IE1 act as antagonists of this defense. Here, we report on the identification of a novel antagonist of host-mediated viral gene silencing which targets the SMC5/6 complex. SMC5/6 belongs to a highly conserved family of protein complexes that act as loop extrusion machines to facilitate the folding of chromatin. While SMC5/6 core factors were not attacked by HCMV, we found that degradation of the SMC5/6 associated protein SLF2 was induced by the viral tegument protein UL35, that is imported into infected cells. This abrogates the accumulation of SMC5/6 at PML nuclear bodies which compromises the entrapment of viral genomes in these subnuclear structures. Since SLF2 is also important for genome stability and pathogenic variants of SLF2 cause the neurodevelopmental disease Atelis syndrome, we speculate that depletion of this factor via a viral tegument protein may also contribute to DNA damage induced during congenital HCMV infection.
SN  - 1553-7374
SN  - 1553-7366
ER  -